Masimo Corporation
General ticker "MASI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $8.7B (TTM average)
Masimo Corporation follows the US Stock Market performance with the rate: 1.2%.
Estimated limits based on current volatility of 2.1%: low 138.34$, high 144.39$
Factors to consider:
- Total employees count: 3600 (-5.2%) as of 2024
- US accounted for 53.8% of revenue in the fiscal year ended 2024-12-28
- Top business risk factors: Technology dependency, Market acceptance of new products, Integration of acquired businesses, Access to capital, Strategic risks and growth management
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-28 to 2026-12-28
- 2024-12-28 to 2025-12-28 estimated range: [128.84$, 196.95$]
- 2025-12-28 to 2026-12-28 estimated range: [136.58$, 208.08$]
Financial Metrics affecting the MASI estimates:
- Negative: with PPE of 38.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.09 <= 0.28
- Positive: 18.93 < Shareholder equity ratio, % of 40.06 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -3.41 <= -0.75
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 0.33 < Operating cash flow per share per price, % of 2.15
Short-term MASI quotes
Long-term MASI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-28 |
|---|---|---|---|
| Operating Revenue | $2,035.80MM | $2,048.10MM | $2,093.90MM |
| Operating Expenses | $1,825.80MM | $1,911.60MM | $2,360.60MM |
| Operating Income | $210.00MM | $136.50MM | $-266.70MM |
| Non-Operating Income | $-16.60MM | $-48.40MM | $-38.60MM |
| Interest Expense | $0.00MM | $50.30MM | $0.00MM |
| R&D Expense | $191.40MM | $175.20MM | $222.80MM |
| Income(Loss) | $193.40MM | $88.10MM | $-305.30MM |
| Taxes | $49.90MM | $6.60MM | $-0.40MM |
| Profit(Loss)* | $143.50MM | $81.50MM | $-304.90MM |
| Stockholders Equity | $1,338.90MM | $1,364.80MM | $1,051.90MM |
| Inventory | $501.00MM | $545.00MM | $459.20MM |
| Assets | $3,210.60MM | $3,041.50MM | $2,625.70MM |
| Operating Cash Flow | $29.40MM | $94.10MM | $196.40MM |
| Capital expenditure | $56.30MM | $87.70MM | $51.10MM |
| Investing Cash Flow | $-1,057.70MM | $-81.20MM | $-51.20MM |
| Financing Cash Flow | $520.40MM | $-57.10MM | $-125.60MM |
| Earnings Per Share** | $2.68 | $1.54 | $-5.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.